Merck & Co. Inc. (MRK)

$ 99.86
   
  • Change Today:
    $2.42
  • 52 Week High: $132.96
  • 52 Week Low: $96.31
  • Currency: US Dollars
  • Shares Issued: 2,531.63m
  • Volume: 15,639,358
  • Market Cap: $252,809m
  • RiskGrade: 92
  • Beta: 0.19

Latest ShareCast News

Merck tops Q3 earnings forecasts despite slower Gardasil demand

By Josh White

Date: Thursday 31 Oct 2024

(Sharecast News) - Pharmaceuticals firm Merck reported a solid third quarter on Thursday, with revenue up 4% year-over-year to $16.7bn, driven by robust sales of its cancer drug Keytruda, although muted demand for the Gardasil HPV vaccine remained a challenge.

Merck to buy drug targeting B-cell diseases for up to $1.3bn

By Michele Maatouk

Date: Friday 09 Aug 2024

(Sharecast News) - Merck said on Friday that it has agreed to buy biotech firm Curon's CN201, a novel investigational clinical-stage bispecific antibody for the treatment of B-cell associated diseases, for up to $1.3bn.

Merck to buy EyeBio for up to $3bn

By Michele Maatouk

Date: Wednesday 29 May 2024

(Sharecast News) - US pharma giant Merck said on Wednesday that it has agreed to buy ophthalmology-focused biotechnology firm EyeBio for up to $3bn.

US close: Stocks recover from three days of losses 28-Mar-2024 ShareCast
US close: Stocks bounce back as labour market so... 02-Feb-2024 ShareCast
Moderna shares surge on cancer trial combo with ... 14-Dec-2023 ShareCast
Merck to buy Caraway Therapeutics for up to $610m 21-Nov-2023 ShareCast
Merck beats on Q1 earnings amid 'strong underlyi... 27-Apr-2023 ShareCast
Merck & Co. posts stronger-than-expected Q4 numb... 02-Feb-2023 ShareCast
Moderna Covid vaccine sales top $18bn 09-Jan-2023 ShareCast
FDA gives AstraZeneca extension on cancer drug a... 15-Dec-2022 ShareCast
Merck to buy Imago BioSciences in $1.35bn deal 21-Nov-2022 ShareCast
Merck afirma que las prescripciones para el Covi... 03-Feb-2022 ShareCast
Merck beats Q4 forecasts amid broad jump in sales 03-Feb-2022 ShareCast
Merck&Co. says oral Covid-19 treatment cuts risk... 26-Nov-2021 ShareCast
Merck and Ridgeback file with FDA for emergency ... 11-Oct-2021 ShareCast
Merck and Ridgeback report good results in trial... 01-Oct-2021 ShareCast
Merck starts third phase clinical trial to evalu... 01-Sep-2021 ShareCast
AstraZeneca, MSD prostate cancer drug gets China... 24-Jun-2021 ShareCast
US government to spend $1.2bn on Merck Covid drug 09-Jun-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Merck Market Data

Currency US Dollars
Share Price $ 99.86
Change Today $ 2.42
% Change 2.48 %
52 Week High $132.96
52 Week Low $96.31
Volume 15,639,358
Shares Issued 2,531.63m
Market Cap $252,809m
Beta 0.19
RiskGrade 92

What The Brokers Say

Strong Buy 10
Buy 11
Neutral 4
Sell 0
Strong Sell 0
Total 25
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 21-Nov-2024

Time Volume / Share Price
15:59 100 @ $99.89
15:59 100 @ $99.88
15:59 184 @ $99.98
15:59 100 @ $99.98
15:59 184 @ $99.98

Top of Page